Navigation Links
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Date:7/7/2009

ommercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

ZOMETA is a registered trademark of Novartis Oncology.

*Editors Note: The FDA has provisionally approved the trade name Prolia(TM) for the proposed indications of treatment and prevention of osteoporosis in postmenopausal women, and treatment and prevention of bone loss in patients undergoing hormone ablation for non-metastatic prostate or breast
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
4. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
5. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
6. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
7. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
10. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Lakeland Industries, Inc. (NASDAQ: LAKE ), a ... and to first responders on the federal, state and ... fiscal 2013 fourth quarter and year ended January 31, ... close and will conduct a conference call on the ... http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call will ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... May 17, 2013 Research ... and outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces ... presentations at the American Psychiatric Association (APA) 166th Annual ... 18-22. The data being presented represent Shire,s ongoing commitment ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... ANF Group, Inc ., a South Florida based ... 170,000-square-foot Joe DiMaggio Children,s Hospital – the first free ... (Photo: http://photos.prnewswire.com/prnh/20110614/FL18288 ) The hospital,s ... designed to earn Gold Leadership in Energy and Environment ...
... June 14, 2011 CVS/pharmacy provides ... at more than 7,200 convenient locations nationwide. Shoppers have come ... larger-than-ever selection of gifts, goods and everyday needs. From popular ... the hottest gear and thoughtful keepsakes perfect for every dad, ...
Cached Medicine Technology:ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 3
(Date:5/20/2013)... when the spotlight is focused on obesity more than ever, ... associated with weight or certain adverse health risks. According to ... of Nutrition Journal , adults who consume candy at ... overweight nor have greater risk factors for cardiovascular disease (CVD) ... frequent candy eaters (less than 3 times per month).1 ...
(Date:5/20/2013)... Brenda Goodman HealthDay Reporter , , SATURDAY, May ... doctors a better view during colonoscopies may help them ... study shows. Colonoscopies are the recommended screening tests ... killer of men and women in the United States. ... flexible tube with a camera mounted on the end ...
(Date:5/20/2013)... HealthDay Reporter , , SUNDAY, May 19 (HealthDay News) -- ... sleep by endlessly and subconsciously waking them up, becomes ... study raises the possibility that it may somehow cause ... Don,t worry just yet if you have sleep ... there may be no connection between the two conditions. ...
(Date:5/20/2013)... News) -- If you,ve got bunions, chances are others ... with a new study finding the condition is often ... the May issue of Arthritis Care & Research ... inherit conditions such as bunions or other toe deformities. ... heritability of common foot disorders in older adults," Dr. ...
(Date:5/20/2013)... 20, 2013) Research presented at Digestive Disease Week ... with diarrhea (IBS-D) and hepatitis C. , An ... IBS-D. In the phase II study, researchers found that ... 50 percent of the individuals treated. , "While ... IBS with constipation, we haven,t seen the same in ...
Breaking Medicine News(10 mins):Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 2Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 3Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3Health News:Many Can Blame Family for Their Bunions 2Health News:Pharmaceutical advances offer new options for health outcomes 2
... Identifying those at risk for diabetes is important because lifestyle ... the disease. Currently an oral glucose tolerance test is used ... costly and inconvenient. A new study finds a cluster of ... type 2 diabetes independently of other risk factors. ...
... the births of their first two children are more likely to ... have the same partner.// These babies are ... The results are the same even when researchers take into account ... decades of birth. ,Researchers speculate that women who ...
... Commonwealth's restaurants, taverns, and nightclubs, and voted to lift ... House and Senate concluded the year's business with a ... approved a sales tax "holiday" designed to spur shoppers ... economy, and approved $102 million in extra spending for ...
... new study shows a new drug alternative to warfarin in ... The research shows the drug ximelagatran appears to be as ... for people at high risk of stroke because of its ... include an increased risk of bleeding and a possible interaction ...
... promising therapy option may be more effective in treating the ... disease that causes persistent redness on the nose and cheeks. ... to the faces of rosacea sufferers. //The new product contains ... Typically it has a different formula and is used to ...
... is so easily cured that Luvie Owens almost forgot she ... her cause for concern: Women who have had the most ... to also get deadlier cancers such as breast, lung and ... is 7.5 times higher. ,The study didn't include men, ...
Cached Medicine News:Health News:Predictors for Type 2 Diabetes 2Health News:Changing Partners may put Expectant Mothers at Risk 2Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4Health News:People with skin cancer at higher risk for other types , 2
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
... HME product line has the right product ... adults and from intubated patients to patients ... for both anesthesia and critical care applications., ... maximum protection for patients and staff members. ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: